BEACHBODY CO INC/THE (BODY)
US0734633094 - Common Stock
Overall BODY gets a fundamental rating of 1 out of 10. We evaluated BODY against 65 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of BODY have multiple concerns. BODY does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
BODY had negative earnings in the past year.
In the past year BODY has reported a negative cash flow from operations.
In the past 5 years BODY reported 4 times negative net income.
In multiple years BODY reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -38.15%, BODY is not doing good in the industry: 78.46% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -93.91%, BODY is doing worse than 75.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -38.15% | ||
| ROE | -93.91% | ||
| ROIC | N/A |
ROA(3y)-28.54%
ROA(5y)N/A
ROE(3y)-57.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 59.97%, BODY is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
BODY's Gross Margin has declined in the last couple of years.
BODY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.57%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BODY does not have a ROIC to compare to the WACC, probably because it is not profitable.
BODY has more shares outstanding than it did 1 year ago.
BODY has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -1.41, we must say that BODY is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.41, BODY is doing worse than 78.46% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that BODY is not too dependend on debt financing.
The Debt to Equity ratio of BODY (0.20) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.41 |
ROIC/WACCN/A
WACC7.92%
2.3 Liquidity
A Current Ratio of 0.76 indicates that BODY may have some problems paying its short term obligations.
BODY's Current ratio of 0.76 is on the low side compared to the rest of the industry. BODY is outperformed by 78.46% of its industry peers.
A Quick Ratio of 0.57 indicates that BODY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.57, BODY is doing worse than 83.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
BODY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -255.37%.
BODY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.83%.
BODY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.89% yearly.
EPS 1Y (TTM)-255.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-26.83%
Revenue growth 3Y-2.89%
Revenue growth 5YN/A
Sales Q2Q%-22.71%
3.2 Future
The Earnings Per Share is expected to grow by 18.40% on average over the next years. This is quite good.
BODY is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.52% yearly.
EPS Next Y-28.34%
EPS Next 2Y24.72%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year-25.14%
Revenue Next 2Y-15.96%
Revenue Next 3Y-10.52%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BODY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BODY. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BODY's earnings are expected to grow with 18.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.72%
EPS Next 3Y18.4%
5. Dividend
5.1 Amount
No dividends for BODY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BEACHBODY CO INC/THE
NYSE:BODY (3/1/2024, 8:04:47 PM)
8.14
-0.17 (-2.05%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap54.62M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -38.15% | ||
| ROE | -93.91% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.97% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-255.37%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-28.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-26.83%
Revenue growth 3Y-2.89%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y